Advertisement

Welke behandeling is effectief voor kinderen met ADHD?

Medicatie en (cognitieve) gedragstherapie
  • Saskia van der Oord
  • Pier Prins
Article
  • 1.5k Downloads

Abstract

Welke behandeling is effectief voor kinderen met ADHD? Wat voegt (cognitieve) gedragstherapie toe aan medicatie? Hoe effectief zijn medicatie, gedragstherapie en de combinatie ervan in het verminderen van de ADHD-symptomen, het agressieve gedrag en in het verbeteren van de sociale vaardigheden en de schoolprestaties van kinderen met ADHD?In dit artikel wordt eerst de meest gangbare medicamenteuze en (cognitief) gedragstherapeutische behandeling van ADHD besproken. Daarna volgt een beschrijving van zowel een klinische studie als een literatuurstudie, verricht door de auteurs om de meerwaarde van gecombineerde behandelingen te onderzoeken. Afgesloten wordt met een aantal aanbevelingen voor de praktijk.

Keywords

ADHD medicatie cognitieve gedragstherapie CGT en medicatie bij ADHD 

Notes

Literatuur

  1. Abikoff, H., Hechtman, L., Klein, R.G., Weiss, G., Fleiss, K., Etcovitch, J., Cousins, L., Greenfield, B., Martin, D. & Pollack, S. (2004). Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 802-811.Google Scholar
  2. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorder, 4th edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.Google Scholar
  3. Barkley, R.A. (2003). Issues in the diagnosis of attention-deficit/hyperactivity disorder in children. Brain and Development, 25, 77-83.Google Scholar
  4. Boo, G. de & Prins, P.J.M. (2007). Social incompetence in children with ADHD: Possible moderators and mediators in social-skills training. Clinical Psychology Review, 27, 78-97.Google Scholar
  5. Boyle, M.H., Jadad, A.R. & Phil, A.R.J. (1999). Lessons from large-scale trials: the MTA study as a model for evaluating the treatment of childhood psychiatric disorder. Canadian Journal of Psychiatry, 44, 991-998.Google Scholar
  6. Carlson, C.L., Pelham, W.E., Milich, R. & Dixon, M.J. (1992). Single and combined effects of methylphenidate and behavior therapy on the classroom behavior, academic performance and self-evaluations of children with attention deficit hyperactivity disorder. Journal of Abnormal Child Psychology, 20, 213-232.Google Scholar
  7. Chronis, A.M., Jones, H.A. & Raggi, V.T. (2006). Evidence-based psychosocial treatments for children and adolescents with attention-deficit/ hyperactivity disorder. Clinical Psychology Review, 26, 486-502.Google Scholar
  8. Conners, C.K., Epstein, J.N., March, J.S., Angold, A., Wells, K.C., Klaric, J., Swanson, J.M., Arnold, L.E., Abikoff, H.B., Elliot, G.R., Greenhill, L.L., Hechtman, L., Hinshaw, S.P., Hoza, B., Jensen, P.S., Kraemer, H.C., Newcorn, J.H., Pelham, W.R., Severe, J.B., Vitiello, B. & Wigal, T. (2001). Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 40 (2), 159-167.Google Scholar
  9. Dopfner, M., Breuer, D., Schurman, S., Metterman, T.W., Rademacker, C. & Lehmkuhl, G. (2004). Effectiveness of an adaptive multimodal treatment in children with Attention-deficit hyperactivity disorderglobal outcome. European Child and Adolescent Psychiatry, 13, 117-129.Google Scholar
  10. Eenhoorn, A.E. (1998). Samen met Joep Loep Sporen na Speuren. Doetinchem: Graviant.Google Scholar
  11. Gezondheidsraad, Rapport van de Gezondheidsraad (2000). Diagnostiek en Behandeling van ADHD. Den Haag: GezondheidsraadGoogle Scholar
  12. Greenhill, L.L., Halperin, J.M. & Abikoff, H. (1999). Stimulant medications. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 503-512.Google Scholar
  13. Jensen, P.S., Martin, D. & Cantwell, D.P. (1997). Comorbidity in ADHD. Implications for research, practice and DSM-V. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1065-1079.Google Scholar
  14. MTA Cooperative Group (1999). A 14-month randomized clinical trail of treatment strategies for Attention Deficit Hyperactivity Disorder. Archives of General Psychiatry, 56, 1073-1086.Google Scholar
  15. Oord, S. van der, Meulen, E.M. van der, Prins, P.J.M., Oosterlaan, J., Buitelaar, J.K. & Emmelkamp, P.M.G. (2005). A psychometric evaluation of the social skills rating system in children with attention deficit hyperactivity disorder. Behavior Research and Therapy, 43,733-746.Google Scholar
  16. Oord, S. van der, Prins, P.J.M., Oosterlaan, J. & Emmelkamp, P.M.G. (2007a). Does brief clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD, European Child and Adolescent Psychiatry,16, 48-57.Google Scholar
  17. Oord, S. van der, Prins, P.J.M., Oosterlaan, J. & Emmelkamp, P.M.G. (2007b). Efficacy of methylphenidate, psychosocial treatments and their combinations in school-aged children with ADHD: A meta-analysis. Submitted. Google Scholar
  18. Oord, S. van der (2005). Critical issues in diagnosis and treatment of children with ADHD. Academisch Proefschrift, Universiteit van Amsterdam. Google Scholar
  19. Pelham, W.E. (1999). The NIMH multi modal treatment study for ADHD: Just say yes to drugs alone? Canadian Journal of Psychiatry, 44, 981-990.Google Scholar
  20. Pelham, W.E., Carlson, C., Sams, S.E., Vallano, G., Dixon, M.J. & Hoza, B. (1993). Separate and combined effects of methylphenidate and behavior modification on the classroom behavior and academic performance of ADHD boys: Group effects and individual differences. Journal of Consulting and Clinical Psychology, 61, 506-515.Google Scholar
  21. Pelham, W.E., Fabiano, G.A. & Massetti, G.M. (2005). Evidence-based assessment of Attention Deficit Hyperactivity Disorder in children and adolescents. Journal of Clinical Child and Adolescent Psychology, 34, 449-476.Google Scholar
  22. Safren, S.A., Otto, M.W., Sprich, S., Winett, C.J., Wilens, T.E., & Biederman, J. (2005). Cognitive-behavioral therapy for ADHD in medicationtreated adults with continued symptoms. Behaviour Research and Therapy, 43, 831-842.Google Scholar
  23. Schachter, H.M., Pham, B., King, J., Langford, S. & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475-1488.Google Scholar
  24. Solanto, M.V. (2002). Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behavioural Brain Research, 130, 65-71.Google Scholar
  25. Spencer, T., Biederman, J., Wilens, T., Harding, M., ‘O Donnell, D. & Griffin, S. (1996). Pharmacotherapy of attention/deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409-432.Google Scholar
  26. Task Force on Promotion and Dissemination of Psychological Procedures (1995). Training in and dissemination of empirically validated psychological treatments: report and recommendations. The Clinical Psychologist, 48, 2-24.Google Scholar
  27. Taylor, E., Dopfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M, Rothenberger, A., Sonuga-Barke, E., Steinhausen, H. & Zuddas, A. (2004). European clinical guidelines for hyperkinetic disorder-first upgrade. European Child and Adolescent Psychiatry, 13, 7-30.Google Scholar

Copyright information

© Bohn Stafleu van Loghum 2007

Authors and Affiliations

  • Saskia van der Oord
    • 1
  • Pier Prins
    • 1
  1. 1.

Personalised recommendations